Sakka Samir G, Hofmann Denis, Thuemer Oliver, Schelenz Christoph, van Hout Nicole
Department of Anesthesiology and Intensive Care Medicine, Friedrich-Schiller-University of Jena, Jena, Germany.
J Cardiothorac Vasc Anesth. 2007 Jun;21(3):351-6. doi: 10.1053/j.jvca.2006.02.031. Epub 2006 Jun 5.
The effects of increasing cardiac output by epinephrine on indocyanine green plasma disappearance rate (ICG-PDR) and gastric mucosal PCO(2) (P(R)CO(2)) were studied as indicators of splanchnic microcirculation.
A prospective clinical study.
Intensive care unit of a university hospital.
With ethics approval and written consent, 12 elective cardiac surgical patients (5 female, 7 male, 71 +/- 8 years) were studied.
Patients underwent pulmonary artery and left atrial catheterization for clinical indications. Measurements were made at intensive care unit admission and 1 hour after (increased) epinephrine treatment. Mean epinephrine dose was changed from 0.02 to 0.08 microg/kg/min.
Heart rate significantly increased from 97 +/- 11 to 106 +/- 12 beat/min. Central venous (10 +/- 3 v 10 +/- 4 mmHg) and left atrial (10 +/- 5 v 11 +/- 5 mmHg) pressures were unchanged. Cardiac index and stroke volume index significantly increased from 2.7 +/- 0.5 to 3.2 +/- 0.5 L/min/m(2) and from 28 +/- 6 to 31 +/- 5 mL/m(2), respectively. Although systemic O(2) delivery and O(2) consumption significantly increased, ICG-PDR did not change significantly (ie, from 18.0% +/- 5.6% to 19.5% +/- 6.4% per minute). P(R)CO(2) and PCO(2) gap (difference between regional and end-tidal PCO(2)) significantly increased from 5.4 +/- 1.0 to 5.9 +/- 1.1 kPa and 1.2 +/- 0.8 to 1.5 +/- 0.7 kPa, respectively.
Increasing cardiac output by epinephrine in patients after cardiac surgery was not associated with a change in flow-dependent liver function but a deterioration in gastric mucosal perfusion.
研究肾上腺素增加心输出量对作为内脏微循环指标的吲哚菁绿血浆消失率(ICG-PDR)和胃黏膜PCO₂(PₐCO₂)的影响。
一项前瞻性临床研究。
一所大学医院的重症监护病房。
经伦理批准并获得书面同意后,对12例择期心脏手术患者(5例女性,7例男性,71±8岁)进行了研究。
患者因临床指征接受肺动脉和左心房插管。在重症监护病房入院时以及肾上腺素治疗(剂量增加)1小时后进行测量。肾上腺素平均剂量从0.02微克/千克/分钟增加至0.08微克/千克/分钟。
心率从97±11次/分钟显著增加至106±12次/分钟。中心静脉压(10±3对10±4 mmHg)和左心房压(10±5对11±5 mmHg)未发生变化。心脏指数和每搏量指数分别从2.7±0.5显著增加至3.2±0.5升/分钟/平方米和从28±6显著增加至31±5毫升/平方米。尽管全身氧输送和氧消耗显著增加,但ICG-PDR没有显著变化(即从每分钟18.0%±5.6%变为19.5%±6.4%)。PₐCO₂和PCO₂差值(局部与呼气末PCO₂之间的差值)分别从5.4±1.0显著增加至5.9±1.1 kPa和从1.2±0.8显著增加至1.5±0.7 kPa。
心脏手术后患者使用肾上腺素增加心输出量与流量依赖性肝功能变化无关,但与胃黏膜灌注恶化有关。